MHP
OXFD

Manatuck Hill Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Manatuck Hill Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-50,000
Closed -$763K – 111
2014
Q3 		$763K Buy
+50,000
New +$766K 0.18% 64

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Manatuck Hill Partners's OXFD Position: Q4 2014 in Review

Manatuck Hill Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2014, closing a stake of 50,000 shares — an estimated $763K sold.

Manatuck Hill Partners first reported a position in OXFD in Q3 2014 and held it in 1 quarter. The position peaked at $763K in Q3 2014. 49 funds tracked by Wall St. Rank hold OXFD as of Q4 2014.

  • Manatuck Hill Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Manatuck Hill Partners sold 50,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2014, an estimated $763K.
  • Manatuck Hill Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2014 and held it in 1 quarter.
  • Manatuck Hill Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $763K in Q3 2014.
  • 49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2014.

Based on Manatuck Hill Partners's 13F filing for Q4 2014, filed 17 Feb 2015.